The ribosome is a highly complex, RNA-based molecular machine that links
genotype to phenotype in every living organism. It is a central regulatory
hub in the cell, and a major antibiotic target. In recent years, our structural
and functional understanding of ribosome action has blossomed, revealing new,
unexpected mechanisms of translation and its regulation in unprecedented detail.
This international ribosome conference has been held every three years since 1968.
It brings together researchers working on all aspects of the ribosome, from
structure and function to its role in disease and use as a drug target. The goal
of the meeting is to inform participants of the state of the art in the field of
protein synthesis and translation and to stimulate interactions between investigators
from all over the world. The conference provides a unique opportunity for students,
young and established researchers from academia and industry to meet, share their
ideas, initiate collaborations, and discuss future directions in this fundamental
and exciting area of the life sciences.
Ribosomes 2025 will be held in person at the Asilomar Hotel & Conference Grounds in
Pacific Grove, California. Situated along the shoreline of the famed Monterey
Peninsula, Asilomar offers breathtaking views of the forest and ocean, as well
as many options for leisure activities and fine dining.
The conference begins on the evening of Sunday, Jun 22 and concludes at noon on
Friday, Jun 27. Talks will be given at Merrill Hall during morning sessions from
9AM - noon, followed by either an afternoon session from 2:00-5:00 PM or an evening
session from 7:00-10:00 PM. Poster sessions will also take place in Merrill Hall
in the afternoons.
(Session topics to be determined)
The Conference Banquet will be held at the famous Monterey Bay Aquarium
on Thursday evening. Transportation will be provided.
Attendance at this conference requires each individual to register.
| John Atkins (Cork) | Nenad Ban (ETH Zürich) |
| Roland Beckmann (Munich) | Scott Blanchard (St. Jude's) |
| Allen Buskirk (Johns Hopkins) | Carlos Bustamante (Berkeley) |
| Jamie Cate (Berkeley) | Barry Cooperman (Univ. Penn.) |
| Tom Dever (NIH) | Sergej Djuranovic (Wash U) |
| Dmitri Ermolenko (Rochester) | Niels Fischer (MPI Göttingen) |
| Chris Fraser (UC Davis) | Kurt Fredrick (Ohio State) |
| Matthieu Gagnon (UTMB) | Ruben Gonzalez (Columbia) |
| Rachel Green (Johns Hopkins) | Nick Guydosh (NIH) |
| Yaser Hashem (Bordeaux) | Zoya Ignatova (Hamburg) |
| Toshi Inada (Tokyo) | Nick Ingolia (Berkeley) |
| Axel Innis (IECB Pessac) | Katrin Karbstein (Scripps) |
| Jeff Kieft (NYSBC) | Sebastian Klinge (Rockefeller) |
| Andrei Korostelev (UMass Worcester) | Laura Lancaster (Santa Cruz) |
| Shura Mankin (UI Chicago) | Harry Noller (Santa Cruz) |
| Yuri Polikanov (UI Chicago) | Marina Rodnina (MPI Göttingen) |
| Karissa Sanbonmatsu (Los Alamos) | Suparna Sanyal (Uppsala) |
| Christian Spahn (Berlin) | Tom Suzuki (Tokyo) |
| Eric Westhof (Strasbourg) | Jamie Williamson (Scripps) |
| Daniel Wilson (Hamburg) | Yong Xiong (Yale) |
| Ada Yonath (Weizmann Inst.) | Marat Yusupov (Strasbourg) |
| Gulnara Yusupova (Strasbourg) |
 |
Harry NollerCenter for Molecular Biology of RNADepartment of MCD Biology University of California, Santa Cruz | ||
|
Laura LancasterCenter for Molecular Biology of RNADepartment of MCD Biology University of California, Santa Cruz | ||
|
Scott BlanchardDepartment of Structural BiologyDepartment of Chemical Biology & Therapeutics St. Jude Children's Research Hospital | ||
|
Kurt FredrickDepartment of MicrobiologyThe Ohio State University |